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Abstract: Oxidative stress is one of the main factors studied to explain the pathophysiological 
mechanisms of inflammatory conditions, such as periodontitis. In this respect, nutrition may 
be of great importance. Actually, research on nutrients’ effects on periodontal diseases  
has expanded to include those influencing the redox status, which correlates to the 
inflammatory process. Dietary fat or lipids are often blamed as the major source of excess 
energy. Consequently, when caloric intake exceeds energy expenditure, the resultant  
substrate-induced increase in citric acid cycle activity generates an excess of reactive oxygen 
species (ROS). In addition, dietary fatty acid intake influences in relative fatty acid 
composition of biological membranes determining its susceptibility to oxidative alterations. 
From this standpoint, here, we reviewed studies analyzing the dietary fat role in periodontal 
disease. Research data suggest that periodontal health could be achieved by main dietary 
strategies which include substitution of saturated fats with monounsaturated fatty acids 
(MUFA) and polyunsaturated fatty acids (PUFA), particularly n-3 PUFA. Maybe in the 
future, we should analyze the diet and provide some advice to periodontitis patients to 
improve treatment outcomes. 
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1. Introduction 
One of the main open questions regarding periodontal diseases is to know all the aetiological and 
pathogenic processes involved. The tendency in medical including dental research has been and largely 
remains to be concentrated on an individual factor, for example, microbial or host. Accordingly, 20th 
century researchers tried to explain common periodontal diseases with the plaque theory. Based on it, 
all periodontal treatments are focused on its control and the restoration of the damage it is presumed to 
have caused. Nowadays, we have obtained good outcomes in periodontal disease control, but it is critical 
to recognize important limitations: a success rate of 100% is hardly attainable, it is difficult to prevent 
the establishment of the disease, the identification of the susceptible population is not feasible, and a 
complete regeneration of the affected tissues, similarly, is presently impracticable. Also, in some forms 
of periodontal disease, such as aggressive periodontitis, plaque is not essential, and in some patients the 
disease has a different course depending on the systemic health. Therefore, in the last few years, the 
importance of the host response has increased markedly [1–3]. In this respect, nutrition may be of great 
importance since it has been implicated in a number of inflammatory diseases and conditions, including 
cardiovascular diseases, type 2 diabetes mellitus, rheumatoid arthritis and inflammatory bowel disease, 
all of which have been associated with periodontitis [4]. 
Nutrition has important long-term consequences for health that contributes to the development and 
progression of chronic diseases. Traditionally, much of the research on diet and periodontal diseases is 
focused on only a few nutrients with well-established roles in the formation and maintenance of 
structural components of oral tissue such as collagen (Vitamin C) and bone (calcium), integrity of 
epithelial tissue (Vitamin A), or in promoting the formation of plaque that harbours periodontal 
pathogens (carbohydrates) [5]. More recently, research on nutrients effects on periodontal diseases has 
expanded to include those influencing redox status, which correlates to inflammatory process. Among 
other nutrients, the implications of dietary fat on periodontal disease has been analyzed from this 
perspective. Consequently, in this review, we collect research on periodontal disease and fat, both in 
humans and animals, with the aim to clarify the possible influence of these components of the diet and 
establish the most appropriate advice for prevention and treatment of this disease. 
2. Periodontal Disease and Oxidative Stress 
Oxidative stress, defined as a persistent imbalance between the production of highly reactive 
molecular species and anti-oxidant defences [6], is one of the main factors studied to explain the 
pathophysiological mechanisms of inflammatory conditions, such as periodontitis [7]. Although the role 
of oxidative stress in periodontal breakdown is complex, there is increasing evidence for compromised 
anti-oxidant capacity in periodontal tissues and fluids independent of smoking, and increased advanced 
glycation end-products levels both in persons with type 2 diabetes and in smokers, which are known risk 
factors for periodontitis [8]. Such oxidation products can increase neutrophil adhesion, chemotaxis, and 
priming in hyper-reactive neutrophils, and might augment the damaging effects of the resultant oxidative 
Antioxidants 2015, 4 324 
 
 
stress [9–11]. In addition to this, the up-regulation of pro-inflammatory transcription factors, such as 
nuclear factor κB (NF-κB) and activating protein-1 (AP-1), in inflamed periodontal tissues contributes 
to reduced glutathione depletion and reactive oxygen species (ROS) generation [12,13]. It has been 
proposed that peripheral blood neutrophil hyperactivity in chronic and aggressive periodontitis exists as 
a constitutional element [14,15], rather than being entirely the result of peripheral priming by cytokines 
or plaque bacterial lipopolysaccharide (LPS) [7]. In addition, there may be possible baseline 
hyperactivity, with low-level extracellular ROS release in the absence of any exogenous stimulus in 
persons with periodontitis [15–18]. 
On the other hand, periodontitis also can influence on serum and/or plasma oxidative markers in 
humans. Several studies have demonstrated an increase in products of oxidative damage in peripheral 
blood from persons with periodontitis compared with control individuals [19–21]. Furthermore, different 
evaluations have shown a decreased anti-oxidant capacity in persons with periodontitis [9,11,22–28]. 
Actually, there is consistent and strong epidemiologic evidence that periodontitis imparts increased risk 
for future cardiovascular disease [29] and a cause/effect relationship has been searched; the key question 
is what the reason for this association is. The presence of a high expression of the receptor for advanced 
glycation end-products (RAGE) in periodontal tissues [30] is an important finding supporting the 
sensitivity of these tissues to products derived from oxidative damage. Moreover, advanced glycation 
end-products, important markers for oxidative stress [31], may promote apoptosis in osteoblasts [32] and 
fibroblasts [33], and this might have an influence on alveolar bone homeostasis and the progression  
of periodontitis. 
3. Dietary Fat and Oxidative Stress 
Lipids or fats consist of numerous water-insoluble compounds, including monoglycerides, digycerides, 
triglycerides, phosphatides, cerebrosides, sterols, terpenes, fatty alcohols, and fatty acids (FAs) [34]. 
These chemical compounds represent more than 50% of plasmatic membrane and their quantity and 
quality are known to have an impact on the composition, characteristics and functions of the biological 
membrane [35,36]. The predominant membrane lipids are phospholipids, which consist in esters of FAs. 
Additionally, FAs also constitute the main component of phospholipids, triglycerides, diglycerides, 
monoglycerides, and sterol esters [34]. In particular, triglycerides (esters of FAs with glycerol) represent 
the foundation of oils and fats (up to 99%) [37]. FAs can vary depending on the chain length, normally 
between 2 and 22 carbon atoms. It could be a short- (2 to 6 carbon atoms), medium- (8 to 10) or  
long-chain (12 or more) FA. They also vary depending on the degree of unsaturation of the FA, and may 
be: saturated FAs (SFA) whose bonds of the free carbon atoms are fully saturated with hydrogen atoms; 
monounsaturated FAs (MUFA), with a double bond, that is, two adjacent carbon atoms that are not 
saturated with hydrogen; or polyunsaturated FAs (PUFA), with two or more double bonds. Unsaturated 
long-chain FAs can be classified into different series according to the position of the last double bond 
from their terminal methylcarbon that is designated as n or ω. Each of these series begins with a 
precursor: in the case of n-3 is α-linolenic acid (ALA); for n-6 is linoleic acid, and for n-9, oleic acid. 
From these precursors, by successive elongation and increases in double bonds (by elongase and 
desaturase enzymes) longer and more unsaturated FAs are formed. The serial number indicates that all 
FAs within a range have a double bond in the corresponding carbon, counting from the first one on the 
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left and including the group called methyl. Phospholipid’s acyl chain normally varies from 14 to  
22 carbons in length and they are either saturated, monounsaturated or polyunsaturated hydrocarbons 
chains [38]. Long-chain FAs included in n-3 and n-6 series also constitute eicosanoids (prostaglandins, 
prostacyclins, thromboxanes, leukotrienes, etc.) that are virtually involved in all tissues and organ 
systems where they perform multiple functions [39]. 
From the nutritional standpoint, the SFA are mainly found in fats of animal origin, some ground 
vegetable fats (coconut and palm) and in margarine. MUFA, mostly represented by the oleic acid, are 
present in large quantities in olive oil, rapeseed oil and in some genetically engineered seeds. Among 
the polyunsaturated linoleic acid, omega-6 series, is the majority among seed oils (sunflower, corn, 
soybean, grape, etc.). Meanwhile, the polyunsaturated ω-3 series are usually present in the fat of fish and 
the majority is eicosapentaenoic acid (EPA), which has 20 carbon atoms and five double bonds, and 
docosahexaenoic acid (DHA), with 22 carbon atoms and six double bonds [40]. Of these FAs, there are 
two that are called essential because they cannot be synthesized by the body, being necessary to provide 
them through the diet. These are linoleic acid (n-6) and α-linolenic (n-3). The first comes from seeds and 
the second is present, for example, in soybeans. From α-linolenic, the aforementioned EPA and DHA 
are formed [41]. 
As mentioned, membrane lipids influence several biochemical parameters, especially at the 
mitochondrial membrane level [38,42,43]. FAs as components of biological membranes strongly 
influence membrane fluidity, which, in turn, may influence many physiological processes involved in 
cell death and survival such as signal transduction, protein import, membrane receptor function and 
metabolite transport [44]. In addition, the chemical reactivity of the FAs from phospholipids is the main 
factor responsible for the membrane’s susceptibility to oxidative alterations [38]. This is particularly 
important because of oxygen, and free radicals are more soluble in the fluid lipid bilayer than in the 
aqueous solution, focusing on these organic regions and becoming membrane lipids’ primary target of 
oxidative damage [45]. The sensitivity of biological membranes to oxidative stress is due to the presence 
of a double carbon-carbon bond in the lipid tails of its phospholipids due to the presence of highly 
unstable electrons near these bonds [20,46–48]. For this reason, polyunsaturated fatty acyl chains of 
phospholipids from biological membranes are very sensitive to oxidation by ROS, increasing 
exponentially as a function of the number of double bonds per FA molecule. In turn, ROS lead to  
carbon-centred radicals within the membranes, resulting in peroxidation of FAs [49]. Therefore, PUFA 
side chains are much more easily attacked by radicals than saturated or monounsaturated side  
chains [50]. Oxidative damage to membrane lipids may be directly generated by ROS as hydroxyl 
radicals or the superoxide anion, or indirectly by some products of lipid peroxidation such as some highly 
reactive aldehydes [51]. Finally, oxidative damage of membrane lipids leads to its alteration and to 
changes in membrane fluidity and, in conclusion, alterations in membrane function [49]. Moreover, lipid 
peroxidation products can produce protein covalent modifications [52]. 
The importance of dietary FAs resides in the fact that biological membranes, including mitochondrial 
membrane, adapt their lipid composition to some extent in response to dietary lipid [53–55]. In other 
words, dietary FA intake influences in relative FA composition of the membrane. Thus, humans and 
animals fed on diets based on olive oil have membranes richer in oleic acid than those fed on diets based 
on sunflower oil, whose membranes are richer in linoleic acid. Further, adaptations of the electron 
transport system in response to the type of dietary fat have been widely reported [56–58]. In this sense, 
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a polyunsaturated fat source will lead to membranes becoming more prone to oxidation than a saturated 
or a monounsaturated source, since a low level of FA unsaturation in cellular membranes will decrease 
cellular oxidative stress. Studies support this idea since their results indicate that experimentally induced 
decreases in liver and brain FA unsaturation also lower oxidative damage in mitochondrial DNA 
(mtDNA) [59]. The high concentration of unsaturated FAs in cellular membrane phospholipids not only 
makes them more sensitive to oxidation reactions, but also enables them to participate in long free radical 
chain reactions. Thus, a low degree of FA unsaturation in biological membranes may decrease their 
sensitivity to lipid peroxidation, which can even protect other molecules against lipoxidation-derived 
damage [42]. This has been widely demonstrated under a wide range of physiological and pathological 
situations using both animal models and humans [60–64]. Regarding SFA, these acids induce a decrease 
of membrane fluidity and permeability. An excess of SFA affects cell membrane activity and in 
particular plasma membrane receptors, which play an essential role in glucose and lipid metabolism [65]. 
The complexity of SFA actions and the possible differences among different individual SFA suggest 
that more research is necessary to better understand the role of SFA and their effects in dietary  
products [66]. 
In spite of these findings, the role of elongase and desaturase system through the inhibition of the 
various components of the different series of FAs must be also considered in relation to FA composition 
of biological membranes [43,67,68]. As is well known, a fine control in the elongation and desaturation 
pathways is crucial for maintaining the membrane function through its effect on fluidity, or certain 
signaling cascades’ mediators [69]. Several studies showed that diet rich in MUFAs (from olive oil) 
stimulates the formation of membranes where the presence of n-3 PUFAs when compared with diets 
rich in n-6 PUFAs (based on sunflower oil as fat source) are increased [70,71]. Likewise, a shift in the 
proportion of n-6 PUFAs with n-3 PUFA-rich diets was observed too. There is a ratio between n-9/n-6 
series suggesting that FA from n-9 series could be more easily incorporated in detriment to n-6 series. 
Diets rich in unsaturated FAs increase levels of MUFAs and rich in n-3 PUFAs increase n-3/n-6  
ratio [72,73]. The maintenance of membrane fluidity is achieved in mammals by a homeostatic 
mechanism and compensation control that maintains an optimal relationship between the proportion of 
saturated and unsaturated FAs [74,75]. This mechanism would explain that no significant changes were 
observed in saturation of membrane lipids since an increase in the n-6 series resulted in a decrease in the 
n-3 and vice versa [43,53]. Animals with a high longevity have a low degree of membrane FA 
desaturation based in the redistribution between types of PUFAs without alteration in the total PUFAs’ 
content and phospholipids redistribution [50]. There is a tendency that the proportion of SFAs remains 
stable, as C18:0, which is largely dependent on the concentration needs of each tissue. However, in the 
case of C16:0, adaptability is observed according to the composition of the diet, with a special ability to 
activate the Δ9 desaturase [38]. In diets rich in FAs of the n-9 series, an increase in MUFAs is shown, 
mainly when oleic acid is administered [64]. In the case of the n-6 series, their membrane levels only 
seem to increase when a large number of their components is administered in the diet [76]. The n-3 series 
is present when good amounts is administered, or when there is a deficiency of n-6, after the two series 
have competed the Δ6 desaturase, which determines the ratio n-3/n-6 [77]. It was suggested, however, 
that high intakes of linoleic acid, even at current levels, were harmful and should be reduced [78]. This 
theoretical argument is based on the possibility that n-6 and n-3 PUFA in the diet could compete with 
each other in elongation and desaturation pathways and that longer-chain n-6 PUFA are precursors to 
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pro-inflammatory eicosanoids, which lastly enhance oxidative molecular species production. Also, high 
susceptibility to oxidation of this edible oil has prompted many warnings concerning benefits to  
health [79]. In addition, it is important to point that dietary lipids are often blamed as the major source 
of excess energy, although it is difficult to differentiate the effects of dietary fat and other energy 
nutrients independent of total energy intake [80]. When caloric intake exceeds energy expenditure, the 
resultant substrate-induced increase in citric acid cycle activity generates an excess of ROS [81]. In turn, 
oxidative stress alters intracellular signalling pathways [76] leading to more oxidative stress generation 
among other harmful consequences. At least that has been noted in some tissues as in a murine model 
where a high fat-diet has been associated with up-regulation of pathways for ROS production and 
oxidative stress in both the liver and adipose tissue, which was followed by an elevation of tumor 
necrosis factor-α (TNF-α) and free FAs in the plasma and liver [82]. 
4. Dietary Lipids and Periodontitis 
There are many reports focused on the relationship of lipids with periodontal disease both, in animals 
and humans, which are presented in Tables 1 and 2, respectively. Research on this relationship can be 
clearly differentiated since it analyzes the role of dietary lipids on periodontal disease from a quantitative 
or qualitative standpoint. Specifically, studies usually evaluate the possible effect of diets with different 
lipid content or FA profile in the diet. At the moment, it is difficult to find human studies that analyze 
the total dietary amount of this macronutrient on periodontitis by total intake estimates or experimental 
interventions. In turn, there is much information from dietary interventions in animals, particularly  
rats [83–86] and mice [87], although rabbits have been used too [88]. Almost all studies have increased 
the dietary fat amount, usually by increasing saturated fat-rich foods [86,87], adding cholesterol [85,86] 
or both [88], to induce atherosclerosis [88], obesity [89] or/and diabetes, in many cases due to energy 
intake increase. Feeding rats with a high-cholesterol diet induced an increase in blood total cholesterol 
and a decrease in high-density lipoprotein (HDL)-cholesterol [86]. These chronic diseases have been 
largely associated with periodontal diseases and there are many reviews on this topic [7,90–94]. Several 
studies have reported associations between consumption of those experimental diets and outcomes 
related to higher alveolar bone destruction [84,85] or inflammation [88]. Others have combined dietary 
treatments with additional methodologies to evaluate the effect of the diet on the biological response to 
periodontal microorganisms. In rats, high cholesterol diets enhanced proliferation of the junctional 
epithelium with increasing bone resorption and cell-proliferative activity associated with application of 
bacterial LPSs and proteases to the gingival sulcus [89]. Excessive intake of this type of nutrients has 
negative effects on periodontal health, especially if they include saturated fat or cholesterol. Several 
markers of inflammation or oxidative stress further are elevated when measured at a local or systemic 
level including 8-hydroxy-2′-deoxyguanosine (8-OHdG) and depletion of reduced glutathione content 
(represented by low reduced glutathione/oxidized glutathione ratios) [83,85,95]. Similarly, the effects of 
bacterial pathogens and their products on production of pro-inflammatory cytokines in fibroblasts were 
augmented [95].
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Table 1. Human studies on lipids effects on periodontitis. 
Study Type 
(Duration) 
Subjects Age (n) 
Main Clinical Outcomes/ 
Periodontitis Definition 
Main Results/Conclusions Reference 
Cross-sectional 
NHANES 1999–2004 
participants (USA) 
≥20 years (9182) 
Periodontitis: PPD ≥ 4 mm & AL ≥ 3 mm 
in any mid-facial or mesial tooth 
Inverse association of n-3 PUFA, DHA, EPA & GLA intake 
with periodontitis prevalence 
[96] 
Cross-sectional 
Patients attended the Sevilla 
University Dental School 
(Spain) 
≥35 years (56) 
Periodontitis: AL ≥ 6 mm in ≥ 2 teeth &  
≥ 1 sites with PPD 5 ≥ mm 
Serum levels of n-6 PUFA, SFA and MUFA were higher in the 
periodontitis group compared to subjects without periodontitis 
which also occurred with peroxida bility index 
[97] 
Cross-sectional 
Patient form dental school of 
the Rio de Janeiro State 
University (Brazil). 
46.0 ± 8.8/31.5 ± 7.5 years (37) 
chronic generalized periodontitis & 
gingivitis were diagnosed according to 
criteria described by the American 
Academy of Periodontology 
Higher serum levels of DHA, DPA, EPA, & AA were observed 
in patients with chronic generalized periodontitis when 
compared with patients with gingivitis 
[98] 
Cohort (5 years) 
Niigata study participants 
(Japan). 
74 years (55) 
Periodontal disease events: n° of teeth with  
AL ≥ 3mm/year 
Negative association of DHA intake with risk of periodontal 
disease events 
[99] 
Cohort (3 years) 
Niigata study participants 
(Japan) 
75 years (235) 
Periodontal disease events: n° of teeth with  
AL ≥ 3mm/ year 
Positive association of n-6/n-3 PUFA ratio with risk of 
periodontal disease events 
[100] 
Cohort (3 years) 
Niigata study participants 
(Japan) 
75 years (264) 
Periodontal disease events: n° of teeth with  
AL ≥ 3mm/year 
Positive association of SFA intakes ratio with risk of 
periodontal disease events in non-smokers 
[101] 
Randomized 
controlled trial (DB)  
(12 weeks) 
Subjects with periodontitis 
(USA) 
18–60 years (30) MGI, PI, PPD 
Supplementation with borage oil (a GLA source) or EPA 
improved PPD, but only the first was statistical significant 
respect to the placebo (an olive & corn oil mixture). 
Additionally, it was the only that also improved MGI. 
[102] 
Randomized 
controlled trial (DB)  
(3/6 months) 
Subjects with advanced 
untreated chronic 
periodontitis (Egypt) 
30–70 years (80) PI, MGI, BOP, PPD & CAL 
Dietary supplementation with a combination of fish oil (EPA & 
DHA-rich) & aspirin after SRP, reduced PPD & salivary levels 
of RANKL & MMP-8 & increased CAL 
[103] 
Abbreviations: AA: Arachidonic acid; AL: Attachment loss; BOP: Bleeding on probing; CAL: Clinical attachment level; CPI: Community periodontal index; DHA: Docosahexanoic acid; DB: Double-blind; DPA: 
Docosapentanoic acid; EPA: Eicosapentanoic acid; GLA: gamma-linolenic acid; MGI: Modified gingival index; MMP-8: Matrix metalloproteinase-8; MUFA: Monounsaturated fatt acids; NHANES: National Health 
and Nutrition Examination Survey; PI: Plaque index; PPD: Peridodontal probing depth; PUFA: Polyunsaturated fatty acids; RANKL: Receptor activator of nuclear factor kappa-B ligand; SFA: Saturated fatty acids; 
SRP: Scaling and root planning; USA: United States of America.  
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Table 2. Animal studies on lipids effects on periodontitis. 
Animal Model 
Gender 
Age/Weight (n) 
Dietary Treatments (Duration) 
Periodontal Intervention 
(Duration) 
Main Results/Conclusions Reference 
New Zealand rabbits with 
dietary-induced 
atherosclerosis 
Male 
2.5 kg (48) 
CoQ10, squalene, or hydroxytyrosol 
supplements after atherosclerosis 
induction (30 days) 
None 
Hydroxytyrosol reduced endothelial activation of gums & 
squalene additionally decreased fibrosis 
[7] 
Obese (by diet) & non-obese 
Wistar rats 
Male 
8 weeks (42) 
High-fat diet combined with exercise 
training or not (4/8 weeks) 
None 
Rats fed a high-fat diet showed higher serum ROM & 
gingival 8-OHdG levels, & gingival GSH/GSSG ratio 
than rats fed a regular diet that were reduced by  
exercise training 
[83] 
Obese (by diet) & non-obese 
C57BL/6J mice 
Both 
4 weeks (80) 
High-fat or standard diet with or 
without moderate exercise after obesity 
development (4 weeks) 
P. gingivalis-soaked or sterile 
ligatures (last week) 
High-fat diet increased P. gingivalis-induced ABL which 
associated to higher serum levels of TNFα, MCP-1, IL-1β 
& lower of IL-6 & IL-12p70. However moderate daily 
exercise decreased ABL & restores cytokines  
normal levels. 
[87] 
Wistar rats 
Male 
8 weeks (24) 
high-cholesterol or regular diet  
(12 weeks) 
None 
High-cholesterol diet decreased alveolar bone density & 
increased TRAP–positive osteoclasts & the expression of 
8-OHdG in the periodontal tissue 
[85] 
Wistar rats with & without 
induced periodontitis 
Male 
8 weeks (32) 
high-cholesterol or regular diet  
(8 weeks) 
Application of LPS & proteases 
or pyrogen free water  
(last 4 weeks) 
High-cholesterol diet increased proliferation of the 
junctional epithelium with increasing bone resorption & 
cell-proliferative activity of the junctional epithelium 
induced by LPS & proteases. 
[86] 
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Table 2. Cont. 
Animal Model 
Gender 
Age/Weight (n) 
Dietary Treatments (Duration) Periodontal Intervention (Duration) Main Results/Conclusions Reference 
Wistar rats with & without 
induced periodontitis 
Male 
8 weeks (32) 
high-cholesterol or regular diet  
(8 weeks) 
Application of LPS & proteases or 
pyrogen free water (last 4 weeks) 
High-cholesterol diet augmented the induced 
production of pro-inflammatory cytokines by 
bacterial products & mitochondrial  
8-OHdG in periodontal tissues 
[95] 
Sprague-Dawley rats with 
induced periodontitis 
Female 
8–9 weeks (95) 
Diets containing 17% fish oil & 
3% corn oil or 5% corn oil only 
(22 weeks) 
Infection with P. gingivalis  
(last 12 weeks) 
Rat fed on diets containing fish oil had  
less ABL 
[104] 
Sprague-Dawley rats with 
induced periodontitis 
Female 
8–9 weeks (82) 
Diets containing 17% fish oil & 
3% corn oil or 5% corn oil only 
(22 weeks) 
Infection with P. gingivalis 381 or 
A7A1-28 (last 12 weeks) 
Diet containing fish oil led to decreased  
IL-1β, TNF-α & enhanced IFN-γ, CAT & 
SOD gingival mRNA levels 
[105] 
BALB/c mice with & 
without induced 
periodontitis 
Female 
6–8 weeks (70) 
Diet containing 10% tuna oil or 
sunola oil (57 days) 
Orally inoculation with P. gingivalis, 
with a mixture of P. gingivalis &  
F. nucleatum or none (last 43 days) 
Diet containing 10% tuna oil decreased ABL 
in inoculated mice 
[106] 
Wistar rats 
Not given 
4 weeks (60) 
Diet containing 10% refined fish 
oil or corn oil (6–8 weeks) 
Tooth movement by 20 g continuous 
force on the lingual side of 1st maxillary 
molars with a lateral expansion spring 
(0/3/7/14 from the sixth week) 
The diet containing 10% fish oil reduced 
tooth movement, n° osteoclasts &  
bone resorption 
[107] 
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Table 2. Cont. 
Animal Model 
Gender 
Age/Weight (n) 
Dietary Treatments (Duration) Periodontal Intervention (Duration) Main Results/Conclusions Reference 
Sprague-Dawley rats with & 
without induced 
periodontitis 
Male 
Adults (39) 
Orally gavaged with n-3 PUFA 
(EPA + DHA) or saline 
supplements (15 days) 
LPS or saline injections 
n-3 PUFA supplements increased IL-1β & OC 
serum levels in LPS-treated rats 
[108] 
Aged & young Wistar rats 
Male 
80–90 g (72) 
Virgin olive, sunflower or fish oil, 
as life-long dietary fat sources 
(6/24 months) 
None 
At endpoint, virgin olive oil fed rats showed 
the lowest age-related ABL, followed by those 
fed on fish oil. Additionally, sunflower oil fed 
rats showed a high degree of fibrosis & a 
moderate degree of inflammation 
[109] 
Wistar rats 
Male 
60 days (28) 
Hyperlipidic or standard diet  
(17 weeks) 
None 
The hyperlipidic diet consumption led to 
development of more periodontal disease sites 
defined by an ABL > 0.51 mm  
(75th percentile) 
[84] 
Abbreviations: 8-OHdG: 8-Hydroxydeoxyguanosine; ABL: Alveolar bone loss; BOP: Bleeding on probing; CAT: Catalase; CoQ10; Coenzime Q10; COX-2: Cicloxigenase-2; DHA: Docosahexanoic acid; EPA: Eicosapentanoic 
acid; F. nucleatum: Fusobacterium nucleatum; GSH/GSSG: reduced glutathione/oxidized glutathione ratio; IFN-γ: Interferon gamma; IL-12p70: Interleukin-12 subunit p70; IL-1β: Interleukin 1-beta; IL-6: 
Interleukin-6; LPS: Lipopolysaccharide; MCP-1: Monocyte chemotactic protein-1; OC: Osteocalcin; P. gingivalis: Porphyromonas gingivalis; PUFA: Polyunsaturated fatty acids; ROM: Reactive oxygen metabolites; 
SOD: Superoxide dismutase; TNFα: Tumor necrosis factor alpha; TRAP: Tartrate-resistant acid phosphatase. 
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On the other hand, qualitative aspects of lipids in the diet also have major importance for the severity 
of periodontal disease. Several studies have investigated the potential effects of different FAs from diet 
or as supplements, on periodontal disease, both in humans and in animal models. The most important 
evidence supporting SFA negative effects derived from a longitudinal study initiated in 1998 in Niigata 
City (Japan), to evaluate the relationship between systemic health and dental diseases [110]. It assessed 
persons aged 70 years old non hospitalized, nor institutionalized; after five years, a dietary assessment 
(by self-administered diet history questionnaire) was conducted and dental health of the cohort was 
followed-up for one year. Eventually, a negative association was found between SFA intake and the 
number of periodontal disease events [100], although only in non-smokers [101]. These results support 
a causal association for saturated fat intake on periodontitis progression, but just in older people, so more 
cohort studies are required to extend that effect to other age groups. 
The effects of PUFA on periodontitis, in turn, have received more attention, and to establish 
conclusions requires making distinctions between n-3 and n-6 PUFA. Particularly, most studies have 
focused on the possible positive effects on periodontitis for polyunsaturated FAs belonging to the n-3 
series, either as preventive or adjunctive during treatment. These FAs include ALA and its derivatives, 
mainly EPA, and DHA. In a cross-sectional study, Naqvi et al. [96] reported negative associations among 
dietary intakes of those three representative n-3 PUFA and periodontitis. As for longitudinal studies, 
results from the Niigata City study are available too. In these, an inverse independent relationship with 
periodontal disease progression was found just for energy-adjusted dietary intakes of DHA after 
controlling for several confounding factors, but not of total n-3 PUFA or EPA [99,101]. In addition, 
there are available data from studies evaluating FAs levels in serum [97,98] but in general they do not 
clarify the role of the different Fa type in periodontal disease. In one of these, it has been reported higher 
levels of n-6 PUFA, SFA and MUFA than in periodontally healthy persons [97]. In other, serum levels 
were compared between patients with chronic generalized periodontitis and those displaying only 
gingivitis. In this, patients with chronic generalized periodontitis had higher levels of arachidonic acid 
as representative of n-6 PUFA but also of n-3 PUFA (DHA, DPA and EPA) [98]. This could indicate 
that higher intake of all these PUFA would facilitate progression of gingivitis to generalized 
periodontitis. However, calculated ratios between these fatty acids, which seem more important, did not 
differ between groups [98]. Moreover, gingivitis patients now could show periodontitis in the future. 
Therefore, to establish any causal relationship, some cohort studies are needed. 
Some interventions have evaluated the utility of using supplements of n-3 PUFA alone or 
supplementing periodontal therapy, both in animals and humans. A combination of DHA and EPA as 
supplement to a regular diet was tested in rats with induced-periodontitis by LPS injections; their use 
was ineffective in preventing alveolar bone loss, either alone or combined with therapy [103,111]. This 
is consistent with data from the transversal study using a National Health and Nutrition Examination 
Survey (NHANES) subset performed by Naqvi et al. [96], who noted that associations hardly changed 
after accounting amounts from supplements containing DHA, EPA, or ALA or after excluding people 
reporting their use, except for ALA. Despite the absence of bone resorption differences, both treatments 
with n-3 PUFA maintained lower gingival levels of different membrane phospholipid mediators in 
respect to only endotoxin-treated rats [111]. When rats received prophylactic treatment, levels were 
similar to healthy controls for prostaglandin E2 (PGE2), leukotriene B4 (LTB4), and plasminogen 
activator factor (PAF), whereas in rats treated only during periodontitis induction, only PGE2 remained 
Antioxidants 2015, 4 333 
 
 
in similar levels although LTB4 levels were lower than in disease controls. On the other hand, serum 
levels of Interleukin(IL)1-β and osteocalcin are higher in rats receiving either n-3 PUFA treatment than 
in only LPS-treated rats. Curiously, PGF2α decreased in respect to both healthy and diseased rats without 
treatment, and only in rats with a non-prophylactic n-3 PUFA treatment [111]. Serum C-reactive protein 
(CRP) levels, in turn, did not show differences among groups [108]. 
In humans, n-3 PUFA supplementation effect was investigated in the treatment of experimental 
gingivitis. Healthy volunteers who discontinued oral hygiene and were treated with fish oil showed a 
significant decrease in gingival index compared to controls [112]. Additionally, in a parallel double blind 
clinical study, advanced chronic periodontitis patients daily treated with fish oil and aspirin after scaling 
and root planning demonstrated reduction in periodontal probing depth and attachment gain after three 
and six months in the n-3 group, compared to baseline and to the placebo-treated group. This suggests 
that supplementation with n-3 PUFA and aspirin resulted in a significant shift in the frequency of 
periodontal probing depths ≤4 mm. Salivary receptor activator of NF-κ-B ligand (RANKL) and Matrix 
Metalloproteinase-8 (MMP-8) levels showed significant reductions in the n-3 group at three and  
six months, and compared to the control at six months [103]. 
Regarding n-6 PUFA, those derived from linoleic acid showed harmful effects, if they were consumed 
at a higher proportion than n-3 polyunsaturated acids. Likewise, Iwasaki et al. [101], using estimated 
energy-adjusted dietary intakes, found that a high n-6 to n-3 PUFA ratio, but not total n-6 acids intake, 
was significantly associated with a greater number of periodontal disease events in the elderly. In fact, 
authors consider dietary n-6 to n-3 PUFA ratio as the main predictor to estimate influence on periodontal 
disease events [101]. An intervention study in humans demonstrated a beneficial effect of n-3 and n-6 
PUFA on periodontitis improving clinical outcomes. Adults with periodontitis received supplementation 
with olive oil as placebo, fish oil as a source of n-3 PUFA (mainly EPA) or borage oil as source of n-6 
PUFA (mainly γ-linolenic acid, GLA). Improvement in gingival inflammation was observed in subjects 
treated with borage oil, whereas improvement in probing pocket depth was seen in those subjects treated 
with either fish oil or borage oil [102]. 
Animal studies in rodents also suggest beneficial effects of a diet with lower n-6 to n-3 PUFA ratio. 
Usually, diets with high content of n-3 PUFA use fish oil as fat source, whereas n-6 acids-rich diets are 
more diverse although corn and sunola oil are the most common sources. Despite diet similarities, they 
differ according to experimental periodontitis induction. Female mice inoculated with bacteria exhibited 
less alveolar bone loss when fed with tuna oil than with the sunola oil treated group [106]. Likewise, 
alveolar bone resorption was also reduced in female rats with induced periodontitis by bacterial 
inoculation treated with fish oil more than with a corn oil-containing diet [105]. In rats, whose teeth were 
subjected to a continuous force, fed diets containing refined fish oil showed less tooth movement, 
accompanied by less bone resorption than those fed diet containing corn oil [107]. Genetic expression 
analyses for several biomarkers (interferon-γ, IL-1β and TNF-α) and different enzymes (cicloxigenase-2, 
catalase and superoxide dismutase) in gums have suggested that this beneficial is consequence of the 
modulating effect of n-3 PUFA on gingival inflammation [104,105]. Additionally, when EPA, DHA and 
ALA levels were analyzed in oral soft tissues, they were higher in animal fed diet rather than in fish  
oil [106]. Periodontal tissue membrane lipid profile changes along with those of inflammation mediators 
levels in both blood and periodontal tissues, combined with improvements of some periodontal 
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outcomes, suggests that dietary modifications of FAs present in biological membranes might protect 
periodontal tissues of local and systemic hazards. 
Recently, interest in the role of MUFA on periodontitis has surfaced. According to research in rats, 
MUFA might offer similar or even better advantages than n-3 PUFA [109]. In the most recent study, 
rats were fed three different diets, which contained virgin olive oil, sunflower oil, or fish oil as fat 
sources, to check their life-long effects. At endpoint, sunflower oil fed rats showed the highest  
age-related alveolar bone loss, followed by those fed on fish oil. Findings concerning bone resorption 
markers (RANKL and Osteoprotegerin) could explain these differences at least in part; RANKL 
expression in gingiva was the highest for virgin olive oil fed young animals, which decreased in old 
animals. Nevertheless, its circulating levels changed similarly for all dietary treatments. For 
osteoprotegerin, the lowest genetic expression was found for fish oil fed animals at six months and 
increased in old animals. On the other hand, animals fed on virgin olive oil showed the lowest 
concentration of plasma levels at six months, but concentration increased with age in both virgin olive 
oil and fish oil fed rats. Similarly, in old animals, the highest levels of lipid peroxidation in the gingiva 
was observed in sunflower oil fed rats, but age differences were only found for virgin olive and fish oil 
fed animal. Histologically, only the sunflower group showed a high degree of fibrosis and a moderate 
degree of inflammation at 24 months, although both sunflower and fish oil group showed a reduction in 
cellularity. Additionally, a wide gene expression analysis on gingival tissue was performed for genes 
implicated in several processes: inflammation (IL-1β, IL-8, IL-6 and TNF-ɑ), apoptosis (Bad, Bax and 
Bcl-2), mitochondrial biogenesis (Tfam, PGC1 and Sirt1), mitochondrial autophagy, and antioxidant 
defense, as well as for electron transport chain Complex I constituents (MT-ND1, MT-ND4 and Ndufs1). 
Results suggest that MUFA or n-3 PUFA positive effects might be because FAs allow mitochondrial to 
maintain turnover through biogenesis or autophagy, and they seem to induce the corresponding 
antioxidant systems to counteract age-related oxidative stress, without inhibiting the mitochondrial 
electron transport chain [105]. In spite of these observations in animals, two nutritional interventions in 
humans [102,112] where olive oil was used as placebo do not support this idea. Both control groups 
showed worst outcomes at the end than those treated with n-3 PUFA [102,112] or even than  
n-6 PUFA-treated groups [102]. Differences with these trials could be to the use of non-virgin olive oil, 
so certain natural bioactive compounds from the minor fraction of virgin olive oil, particularly phenolic 
components, were not present. Among others, hydroxytyrosol has demonstrated important antioxidant 
and anti-inflammatory properties, which could be of interest for the prevention of diseases traditionally 
related to oxidative stress, such as cardiovascular diseases and cancer [113]. Among other findings, it 
has shown to protect LDL particles from lipid peroxidation both in vitro [114,115] and in vivo [116,117], 
as well as to inhibit prostaglandin E2 synthesis [118]. Another major compound present in olive oil, 
squalene [119], also has shown important antioxidant properties in vitro [120,121] and it has been 
suggested that it may have a critical role reducing sunlight-derived free radical oxidative damage to the 
skin [121,122] since it is one of the main lipids in its surface [123]. Results from an experimental model 
of atherosclerosis and stetatohepatitis in rabbits (by a 50 days’ treatment with a saturated fat-rich diet 
with cholesterol) manifested some inflammation features also at gingival level. After development of 
atherosclerosis, subsequent intervention with hydroxytyrosol reduced endothelial activation and, with 
squalene, additionally decreased fibrosis. The results suggest that the gingival vascular changes observed 
after the atherosclerotic diet have been reversed by hydroxytyrosol and squalene [88]. Furthermore, it is 
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important to note that interventions use olive oil as supplemental placebo, and it might not modify the 
largely lipid profile of diet. This would not markedly increase the content of MUFA in biological 
membranes, which could be another reason for the positive role of olive oil as a fat source. 
5. Conclusions 
Nowadays, to treat periodontal disease, the treatment approach is based on the concept that the 
biofilm/bacteria are the main cause. The new thrust in periodontal medicine highlights the implications 
of systemic health in the homeostatic equilibrium between aggression and host response. Therefore, it is 
mandatory to know in depth details of the systemic health status of periodontal patients. The desirable 
outcome would be to recognize general health factors that could influence, if modified, periodontal 
disease control. It is known that the main systemic diseases such as diabetes and cardiovascular disease 
can be prevented with the control of risk factors. The diet, especially the lipids, produces an impairment 
of the general conditions. Some data show that lipids could affect the natural development of periodontal 
disease. In that sense, animal experiments have shown fat-rich diets have an adverse effect on periodontal 
health [83,85–87,95], which often correlates with a higher degree of oxidative stress [83,85,95]. In all 
of them, increase of fat was due to increase of saturated fat but it would be interesting to know what 
would happen with other fat types with different susceptibility to lipid peroxidation. In spite of this 
appreciation, these diets usually are energy-dense diets, and excessive energy intake also has been 
associated with high oxidative stress levels [81]. Regarding the type of dietary fat, longitudinal studies 
in humans would indicate that the dietary n-3/n-6 PUFA ratio is important [96,100]. This is in line with 
the fact that, at the moment, studies on n-3 PUFA with supplements have not been entirely successful in 
animals (at least regarding bone loss), although in humans some slightly better clinical outcomes have 
been obtained [103,112], although the same effect was found across these studies [102]. However, when 
treatments consisted of diets with high n-3/n-6 ratios, it was found to clearly have positive results [105,106], 
but for now this has only been tested in animal models. On the other hand, the role of total intakes of 
PUFA has been discussed more extensively [97,101]. Lastly, while MUFA susceptibility to oxidation is 
considered low [42,50], studies evaluating MUFA-rich diets are limited and they offer conflicting 
results. In any case, based on the significant lack of studies in humans, it is difficult to provide dietary 
advice. Possibly, in the future, we should analyze the diet and give some advice to patients to improve 
treatment outcomes. 
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